Loading...
Keywords
Last Name
Institution

Connection

Rebecca Rentea to Botulinum Toxins

This is a "connection" page, showing publications Rebecca Rentea has written about Botulinum Toxins.

 
Connection Strength
 
 
 
1.988
 
  1. Svetanoff WJ, Lim-Beutal IIP, Wood RJ, Levitt MA, Rentea RM. The utilization of botulinum toxin for Hirschsprung disease. Semin Pediatr Surg. 2022 Apr; 31(2):151161.
    View in: PubMed
    Score: 0.825
  2. Rentea RM, Noel-MacDonnell JR, Bucher BT, Dorman MR, Lautz TB, Pruitt LCC, Oyetunji TA. Impact of Botulinum Toxin on Hirschsprung-Associated Enterocolitis After Primary Pull-Through. J Surg Res. 2021 05; 261:95-104.
    View in: PubMed
    Score: 0.757
  3. Rice-Townsend SE, Nicassio L, Glazer D, Avansino J, Durham MM, Calkins CM, Rentea RM, Ralls MW, Wood RJ, Rollins MD, Garvey EM, Lewis KE, Reeder R, Smith CA. Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery. J Pediatr Surg. 2022 Jun; 57(6):1033-1039.
    View in: PubMed
    Score: 0.204
  4. Ahmad H, Rentea RM, Knaus ME, Wilbur JG, Halaweish I, Langer JC, Levitt MA, Wood RJ. Routine botulinum toxin injection one month after a Swenson pull-through does not change the incidence of Hirschsprung associated enterocolitis. J Pediatr Surg. 2022 Aug; 57(8):1453-1457.
    View in: PubMed
    Score: 0.202
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.